PHOENIX, AZ — December 22, 2025 — DataBiologics, a leading real-world data intelligence platform, today announced that Luke Malanga has been appointed Chief Executive Officer.
Malanga served as the company’s Chief Operating Officer and Head of Product for the past 6 years, where he has played a central role in shaping DataBiologics’ product strategy, and strengthening partnerships across healthcare providers, medical device companies, and researchers.
Malanga succeeds Leah Braddell, who will transition into a focused role leading data strategy and clinical research initiatives. Braddell will continue to support the company as a senior consultant and advisor — remaining deeply involved in guiding DataBiologics’ long-term vision.
“Luke has been at the center of our product innovation and execution from the early days of our company,” said Dr. Chris Rogers, co-founder and Chief Medical Officer. “His leadership, operational discipline, and deep understanding of our customers make this a natural and exciting next step for the company.”
“DataBiologics was founded on the belief that real-world outcomes should guide how we improve patient care,” said Dr. Jay Bowen, co-founder and Chief Scientific Officer. “Luke understands that mission at a fundamental level. Under his leadership, DataBiologics will strive to fully leverage its growing dataset — transforming real-world evidence into predictive insights that shape clinical decisions, accelerate research, and influence the adoption of innovative care solutions.”
Under Malanga’s leadership, DataBiologics will continue expanding its provider network, deepen partnerships with industry, and accelerate outputs from the registry.
“I’m honored to step into this role at such a pivotal time for DataBiologics,” said Malanga. “We have an enormous opportunity to empower clinicians, elevate evidence-based care, and continue developing the most trusted real-world data platform in the field. I look forward to building upon our strong foundation and advancing the next era of DataBiologics.”
DataBiologics thanks Braddell for her leadership and continued commitment to shaping the company’s data strategy.
About DataBiologics
DataBiologics is a real-world outcomes platform designed to help clinicians, researchers, and medical device companies understand treatment effectiveness. With a growing network of contributing providers and millions of data points, DataBiologics delivers evidence-based insights that advance patient care, support clinical research, and inform product development.
Contact: info@databiologics.com




